Oscar B. R.
- Country
- Spain
- Department
- Urology
Research Overview
Data & Insights
Has run more than one trial at 3 of 22 partner sites.
Specializations
Urologic Oncology
The investigator specializes in the treatment of non-muscle invasive bladder cancer (NMIBC), with particular emphasis on advancing therapeutic approaches for patients who have not responded to conventional treatments.
- Bladder Cancer Management
- Novel Immunotherapy Applications
- Treatment-Resistant Disease
Focused on evaluating innovative therapeutic combinations for bladder cancer treatment, including immunotherapy-based approaches and antibody-drug conjugates.
Immunotherapy Research
Demonstrates expertise in investigating combination immunotherapy strategies, particularly in the context of urological malignancies. The research encompasses novel therapeutic combinations to enhance treatment outcomes.
- Targeted Therapy Development
- Combination Treatment Approaches
- Response Assessment Methods
Explores the potential of dual-targeting therapeutic strategies in managing complex urological cancers.
Treatment Innovation
Actively involved in developing alternative treatment pathways for patients who have exhausted standard therapeutic options, with a focus on high-risk disease management.
- Treatment-Resistant Cancer
- Clinical Response Evaluation
- Multi-Modal Therapy
Specializes in evaluating therapeutic efficacy through systematic assessment of clinical responses in complex urological conditions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.